BeiGene, Ltd. (ONC) Stock Forecast
ONC analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 27 analysts
- Price target
- $436.46 average of analyst targets
- Upside to target
- +18.3% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $2.34
- 52-week range
- $260.27 – $377.47
ONC analyst ratings
27 analystsNumber of analysts at each rating.
ONC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ONC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.88 | $1.56 | $2.24 | $1.09 | +72.3% | 12 |
| Current fiscal year (2026) | $7.64 | $6.63 | $8.83 | $2.53 | +202.1% | 17 |
| Next fiscal year (2027) | $10.25 | $6.53 | $15.24 | $7.64 | +34.2% | 17 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ONC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.76B | $1.72B | $1.79B | +24.5% | 12 |
| Current fiscal year (2026) | $6.77B | $6.67B | $7.14B | +26.8% | 31 |
| Next fiscal year (2027) | $7.78B | $7.17B | $8.49B | +14.9% | 32 |
ONC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ONC revenue: reported and forecast
ONC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.70 | $1.82 | $1.82 | $1.88 | $1.88 | +10.4% | 2 up · 0 down |
| Current fiscal year (2026) | $6.44 | $7.60 | $7.60 | $7.64 | $7.64 | +18.7% | 3 up · 0 down |
| Next fiscal year (2027) | $9.63 | $10.28 | $10.32 | $10.25 | $10.25 | +6.5% | 2 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ONC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ONC beat in 8 of 12.
What analysts expect from ONC
27 analysts cover BeiGene; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $436.46, 18.3% above the latest close of $369.06. Analysts expect earnings of $7.64 per share for 2026, +202.1% from a year earlier. For 2027 the average estimate is $10.25 per share on revenue of $7.8 billion. BeiGene beat the EPS estimate in 8 of the last 12 quarters.
Related: ONC income statement, ONC key metrics, ONC chart. See the ONC stock overview for the latest quote and news.
ONC forecast FAQ
What is BeiGene's price target?
The average analyst price target for BeiGene is $436.46, 18.3% above the latest close of $369.06.
Is BeiGene a buy, hold or sell?
Of 27 analysts covering BeiGene, 19 rate it a strong buy, 7 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is BeiGene's EPS forecast?
Analysts forecast $7.64 per share for 2026 (range $6.63 to $8.83); for 2027 the estimate is $10.25.
What is BeiGene's revenue forecast?
The average revenue estimate for 2026 is $6.8 billion, growth of 26.8%; for 2027 it is $7.8 billion.
When does BeiGene report earnings?
BeiGene is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $2.34.
Does BeiGene usually beat earnings estimates?
BeiGene reported EPS at or above the analyst estimate in 8 of the last 12 quarters.